Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
http://www.investmentu.com/article/detail/19039/phase-2-biotech-investing#.WM2ZLfnyvIU
that appears to be where prolanta is at the moment...
Oncolix as of Jan 2017
https://www.b2match.eu/ucis2017/participants/24
orphan drug designation
8 patents
positive data results?
$15M raised previously in financing
currently AEPP sits at $2.3M. What do you think it will be worth with all of the above confirmed? not less than this...
they turned a private startup into a $20 million dollar company in three years. i don't believe they held anything close to orphan drug designation with positive lab results at the time either.
currently AEPP is at a $2.3M market value
redman and payne built opexa pharma in three years into a $25M company and cashed in.
oncolix is 11 years old. hmmm
http://www.bizjournals.com/houston/stories/2004/10/04/daily45.html
The stock deal calls for shareholders of privately held Opexa to get 2.5 million shares of PharmaFrontiers, a deal valued at $20 million based on PharmaFrontiers Thursday closing price of $8 per share.
just saying...
this stock has dollars written all over it. who knows, but damn...
long term...i'm betting that they're looking nasdaq or buyout. they've done it before and i suspect they made an enormous amount of cash on the opexa deal. look what happened with opexa's stock as it went public. good lord...
news about takeover. news about what oncolix is and what their plans are.
news about data results and financing. so much to find out here...
if they come out next week and start talking nasdaq don't be surprised. who knows though.
can't believe how under the radar this still is.
.35
same share set up as now i think. or tighter.
and that's before it was a biotech with patents and MD Anderson trials. that's when it was a real stinky pink sheet that was switching to oil in peru or some other nonsense. that was at .35, i repeat.
full disclosure...i think that's the wrong evrc. aepp that was evrc had an IPO in 2013 with the same share structure we have now i think. don't know what the price was. sorry for the confusion
nonetheless, aepp was just up as .35
one hour left to get in for pennies?
squeeze that fool
lol @ whoever is messing with ascm
AEEP used to be EVRC. EVRC traded around $10 a share for several years with about 10M shares out.
now we might be talking about a brand new biotech with patents, orphan drug status, MD Anderson trials, $15M in financing, two lifetime biotech guys with excellent track records as officers. and what, maybe a 30M trading float? heh
and ascm has gone into hiding...even as the price has gone up.
tick tock...
like, if they announce a florist is taking over the shell, i think we might be in trouble. lol
after hours release would give the market the entire weekend to digest the news. if the news is what we think, this would be a nice setup IMO.
unless it's scammy news, then save it for monday. lol
also take note that ascm has backed off for a while now...he knows.
i'd be shocked if this didn't finish strongly. if nothing else, the shorts had better cover before the weekend.
where are the sellers? come on folks, let's drop this a tick for some last minute cheap buying.
dang...
ok, but i'm not paying that price today ;)
that's probably going to be the deal of the year in a week...
fishing here for some cheapies...sell to me!
just a tiny bit of volume and it flies. only a matter of time.
small dip mostly caused by a few ASCM short sells and a tiny bit of retail flipping. but yeah, nobody here is really selling. it's coming...
we knows its coming really soon.
i'm not even gonna sweat what happens in the meantime...
http://www.goerie.com/news/20170304/ex-erie-penny-stock-company-found-in-default
A former Erie-based company that traded in penny stock has lost a fraud lawsuit by default to the Securities and Exchange Commission.
The case, involving civil charges of a "pump-and-dump" stock scheme, is heading toward the same resolution against the suit's other defendant, who is the company's chief executive.
A federal judge on Friday ordered the default judgment against the company, the Fortitude Group Inc.
U.S. District Judge Barbara Rothstein granted the judgment at the request of the SEC and upon the recommendation of U.S. Magistrate Judge Susan Paradise Baxter, who ruled against Fortitude in U.S. District Court in Erie on Feb. 10.
Baxter is next due to review a request for default that the SEC filed on Tuesday against Thomas J. Parilla, the CEO of the now-defunct Fortitude, formerly at 1001 State St.
The SEC filed the motion for default against Parilla for the same reason it filed one against Fortitude — because the defendants failed to properly respond to the suit the SEC filed against them on Feb. 29, 2016.
Fortitude never filed a response. Parilla, representing himself, filed a five-page motion in April asking to dismiss the case. The motion was in the form of a letter rather than the proper format for civil filings, and the SEC said the motion was without "any cognizable argument."
Baxter in December ordered Parilla to file a proper motion to dismiss by Jan. 13. He did not, which led the SEC to ask for a default judgment.
In granting the default judgment against Fortitude, Rothstein permanently enjoined the company from violating SEC rules against providing false and misleading statements.
The SEC wants Parilla fined and banned from participating in the sale of penny stock, which typically sells for less than $1 a share. Parilla said in his dismissal motion that he is a victim and did nothing wrong.
He could not be reached for comment on Friday. A person who answered the phone at what had been Parilla's Erie residence said he had moved to New Mexico.
The SEC is claiming Parilla artificially inflated, or pumped, the value of Fortitude's penny stock so he could sell it, or dump it, to make money.
The SEC is claiming the scheme involved Fortitude making false statements about its purported entry into the legal marijuana industry in Colorado three years ago. Fortitude claimed its portfolio included a purported marijuana vaporizer called "VaporVites," according to court records.
Penny stocks are not listed on the New York Stock Exchange or other major exchanges, but are traded via electronic services such as the Over-The-Counter bulletin board. The stocks are considered highly speculative and volatile, which can lead to big gains and losses.
still more confirmation...
did you get back in?
8 patents
orphan drug designation
MD Anderson sponsored FDA trials
for pennies on the OTC? too good to be true?
mine are for sale for a dollar. lol. anyone?
very few shares out there as well...
that's what i'm talking about.
oh no doubt.
either way we know it's coming really soon. OTC markets has updated their page. This is a done deal. The big question is what's inside the box?
which could easily be tomorrow before open...